Advancements in Poultry mRNA Vaccines with Nanoparticles

Researchers from the University of Connecticut (UConn) have made significant strides in combating infectious diseases in poultry through innovative mRNA vaccine technology. Collaborating across disciplines, a team led by Mazhar Khan, along with Challa V. Kumar and graduate students Anka Rao Kalluri and Aseno Sakhrie, has developed a novel protein-based nanoparticle designed to enhance the effectiveness of mRNA vaccines. This research culminated in their findings published in the journal Vaccines.

Understanding the Threat: Infectious Bronchitis Virus

Infectious bronchitis virus (IBV), a highly transmissible coronavirus, poses a substantial threat to poultry worldwide, costing farmers millions in losses annually. Traditional vaccination methods such as live attenuated and killed vaccines face several challenges, including:

• Risk of viral reactivation and mutation.
• Shorter shelf life requiring cold storage.
• Necessity of adjuvants to enhance vaccine efficacy.

These limitations have motivated researchers to seek alternative solutions that can improve both the stability and effectiveness of vaccines.

The Innovative Nanoparticle Approach

The newly developed mRNA vaccine circumvents the pitfalls of traditional vaccines by not containing any live virus. Instead, it incorporates mRNA that encodes the spike protein of the virus, designed to trigger an immune response effectively. However, mRNA vaccines historically suffer from stability issues, often degrading rapidly under non-controlled temperature conditions. The nanoparticle developed by Khan and Sakhrie addresses this instability:

• The nanoparticle comprised a modified form of a common protein derived from bovine serum albumin, created to protect the mRNA from degradation.
• Amino groups are attached to the nanoparticle, which not only stabilize the mRNA but also assist in evading enzymatic breakdown by nucleases in the body.

Key Advances in Vaccine Delivery

By enhancing the stability of mRNA, the nanoparticle significantly boosts the overall effectiveness of the vaccine:

Future Directions: Streamlining Vaccination Methods

As the research progresses, the team is investigating alternative administration methods. Currently, vaccination involves individual injections for each chick, which is not only labor-intensive but also stressful for the birds. Future studies aim to determine whether the vaccine can be effectively administered via a spray:

• This method could streamline the vaccination process for large flocks, reducing stress for the chicks and workload for farmers.

Broader Implications for Vaccine Development

While IBV currently does not pose a direct concern for human health, the technology developed could facilitate advancements in human vaccine application. The versatile nanoparticle platform allows for rapid adaptation to emerging diseases. Researchers could potentially modify the mRNA sequence for other pathogens swiftly:

“The flexibility of this nanoparticle technology opens avenues for future vaccine development against a variety of diseases, ensuring swift responses to public health challenges.” – Mazhar Khan

Conclusion

The breakthrough in nanoparticle-based mRNA vaccination for poultry signifies a crucial step toward improving animal health and welfare. As the researchers continue refining their approach, the implications of their work may extend beyond poultry, aiding in the development of more effective human vaccines as well.

References

Aseno Sakhrie et al. (2025). Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection. Vaccines. DOI: 10.3390/vaccines13060568

For additional updates and insights into scientific developments, feel free to subscribe to platforms like Phys.org.